Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-10-22
2000-10-17
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514634, 514742, A61K 31155, A61K 3104
Patent
active
061333204
ABSTRACT:
Primary and secondary osteoporosis in a female or a male mammal is treated by administering thereto a nitric oxide synthase substrate, a nitric oxide donor or both, optionally; in further combination with one or more of an estrogen, a progestin, an anabolic steroid. Nitric oxide substrate or donor also can be combined with one or more of other medications acting on bone, such as bisphosphonate, calcitonin, fluoride, androgen and other novel therapeutic agents. Either nitric oxide donor or substrate by itself or combination with other medications as described above can be used in both women and men, (preferably human) for prevention and treatment of osteoporosis and other metabolic bone disorders.
REFERENCES:
patent: 4393226 (1983-07-01), Witiak et al.
patent: 5364841 (1994-11-01), Cooper et al.
patent: 5622973 (1997-04-01), Morriello et al.
Kasten et al. "Potentiation of osteoclast . . . Synthase" Soc. Natl. Acad.Sci. USA vol. 91, pp. 3569-3573 (1994).
Visser et al. "Arginine . . . Osteoporosis" Medical Hypotheses vol. 43, pp. 339-342. (1994).
Wimalawansa et al., "Nitric Oxide Donor Alleviates Ovariectomy-Induced Bone Loss," Bone, 18(4):301-304, 1996.
Wimalawansa et al., "Replacement Therapy with Nitric Oxide or Nitric Oxide Dornor In Vivo, Maintains the Bone Mass in Rats After Ovariectomy," World congress on Osteopororis, Abstract No.PTU 759, Amsterdam, May 18-23, 1996.
Wimalawansa, "Steroid-Induced Osteoporosis can be Prevented with Nitric Oxide," American Society for Bone and Mineral Research, Sep. 7-11, 1996.
Yallampalli et al., "Calcitonin Gene-Related Peptide Reverses the Hypertension and Significantly Decreases the Fetal Mortality in Pre-Eclampsia Rats Induced by N.sup.G -Nitro-L-Arginine Methyl Ester," Human Reproduction, 11(4):895-899, 1996.
Wimalawansa Sunil J.
Yallampalli Chandrasekhar
Board of Regents , The University of Texas System
Criares Theodore J.
LandOfFree
Treatment of osteoporosis and metabolic bone disorders with nitr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of osteoporosis and metabolic bone disorders with nitr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of osteoporosis and metabolic bone disorders with nitr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-469661